biotech / news / / Reuters
Several drugmakers have been developing lower-cost versions of Novo Nordisk's diabetes drug Ozempic.
India was the first major market to launch copycat semaglutide after patent expiries in March.
KEY POINTS
- Novo Nordisk cut Ozempic and Wegovy prices in India following the entry of generics.
- Health Canada is reviewing eight applications for generic semaglutide from different companies.
- Canadian generic medications are typically 45% to 90% cheaper than brand-name versions.
COMPANIES
Summarized by Newsio from Reuters. How we summarize →